07/10/2025 | Press release | Distributed by Public on 07/10/2025 01:44
The University of Toledo will host a symposium next month to discuss the latest breakthroughs in cancer research, highlight the innovative work of UToledo scientists and provide networking opportunities to those studying the disease.
The Toledo Cancer Research Symposium will be held from 8 a.m. to 4:15 p.m. Friday, Aug. 1, in the Mahogony Ballroom of the Delta Hotels Toledo on the University's Health Science Campus.
Attendance is free, but individuals must register by Friday, July 18. Links to register to attend or to submit an abstract are available on the event website.
This year's symposium will feature moderated panel discussions on tumor biology, drug resistance and tumor microenvironment, cancer epigenetics, cell cycle regulation in cancer, drug discovery and delivery, and clinical perspectives and artificial intelligence in cancer research.
Dr. Peter A. Jones, president and chief scientific officer of the Van Andel Institute in Grand Rapids, Michigan, will deliver this year's keynote address.
Jones, a molecular biologist, is a past president of the American Association for Cancer Research, and a member of the National Academy of Sciences and the National Academy of Medicine.
The author of more than 300 scientific papers, Jones helped to pioneer the field of epigenetics, which focuses on how lifestyle and the environment can cause changes in how individual genes work.
"We're excited to bring the Toledo Cancer Research Symposium back to life," said Dr. Jian-Ting Zhang, professor and chair of the Department of Cell and Cancer Biology in the College of Medicine and Life Sciences. "This gathering not only showcases the cutting-edge cancer research being conducted at UToledo and across our region, but also fosters collaboration among scientists, clinicians and students united in the fight against cancer.
"We are especially fortunate to have Dr. Peter Jones as our keynote speaker and are deeply grateful to our enthusiastic sponsors and dedicated organizing committee."
Sponsors of this year's event include Dr. Natalie Rizk, a UToledo Health breast surgical oncologist, BD Biosciences, BioLegend, Fisher Scientific, MedChemExpress, Sydlabs and 10X Genomics.
Additional information and a full schedule are available on the Toledo Cancer Research Symposium website.